ASIRO (7378) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
6 Jun, 2025Executive summary
Achieved record-high Q1 FY2025 revenue of ¥1,581 million, up 63.7% year-over-year, and operating profit of ¥406 million, reversing a prior year loss.
Net income attributable to owners was ¥269 million, up 62.9% sequentially and reversing a ¥128 million loss last year.
Set FY2025 targets at ¥6.33 billion revenue and ¥1.27 billion operating profit, both above initial mid-term plan.
Strong growth in legal media and HR segments, with continued investment in insurance product development.
Company plans a significant update to its business model, with details to be announced in 2Q.
Financial highlights
Adjusted EBITDA for Q1 was ¥423 million, up 938% year-over-year; EBITDA was ¥444 million, up 584%.
Gross profit margin increased to 43.8% from 33.8% year-over-year.
Operating margin improved to 25.7% from 13.8% in the previous quarter.
EPS was ¥36.89, up from -¥17.76 last year.
Cash and deposits at quarter-end were ¥1,534 million, down ¥63 million from the previous quarter.
Outlook and guidance
Full-year FY2025 guidance maintained: revenue ¥6,326 million (+31.8%), operating profit ¥1,265 million (+285%), net income ¥820 million (+540%).
1Q revenue progress reached 25% of full-year target, with operating profit at 32.1% and net income at 32.4%.
Management targets continued profit growth and cost control.
Focus remains on achieving ¥20 billion in revenue in the shortest time and pursuing further long-term growth.
Latest events from ASIRO
- Revenue up 8.9% YoY, profit down, dividend policy revised, and HR business divested.7378
Q1 202623 Mar 2026 - Record revenue and profit growth, HR dispatch divested, and AI-focused strategy launched.7378
Q2 202511 Dec 2025 - Record profit growth and business focus drive strong FY2025 results and positive FY2026 outlook.7378
Q4 202511 Dec 2025 - Record profit and margin growth, guidance raised, and new insurance product launched.7378
Q3 202512 Sep 2025 - Revenue and profit soared past targets; FY2025 outlook signals major earnings growth.7378
Q4 202413 Jun 2025 - Revenue up 44% YoY, impairments led to net loss, but outlook was raised.7378
Q3 202413 Jun 2025 - 45% YoY revenue growth, but impairment losses led to a net loss and negative EPS.7378
Q2 202413 Jun 2025